Prolongation of cardiac allograft survival by pretransplant administration of cyclosporine and donor-specific dendritic cells
Choti, M.; Lenrow, D.; Roza, A.; Markmann, J.; Naji, A.
Transplantation Proceedings 21(1 Pt 1): 478-479
1989
ISSN/ISBN: 0041-1345 PMID: 2565055 Document Number: 333592
Document emailed within 1 workday
Related Documents
Farges, O.; Buffello, D.; Shi, Y.M.; Moufetier, A.; Bismuth, H. 1995: Prolongation of cardiac allograft survival following intraportal injection of donor antigen is inhibited by cyclosporine a Transplantation Proceedings 27(4): 2525-2527Lenrow, D.A.; Markmann, J.F.; Shachner, M.S.; Naji, A. 1989: Prolongation of cardiac allograft survival by suppressor T cells (Ts) generated in vitro using cyclosporine Transplantation Proceedings 21(1 Part 1): 473-474
Davies, C.B.; Cofer, B.R.; Alexander, J.W. 1991: Effects of donor-specific transfusion, cyclosporine a and FK 506 on rat cardiac allograft survival Transplantation Proceedings 23(6): 3314-3315
Kamei, T.; Callery, M.P.; Flye, M.W. 1990: Pretransplant portal venous administration of donor antigen and portal venous allograft drainage synergistically prolong rat cardiac allograft survival Surgery 108(2): 415
Tchervenkov, J.I.; Epstein, M.D.; Alexander, J.W.; Schroeder, T.J. 1989: The effect of donor-specific blood transfusion, cyclosporine, and dietary prostaglandin precursors on rat cardiac allograft survival. II. Effectiveness of a 24-hour induction period with DST and CsA in inducing long-term graft survival Transplantation 47(1): 177-181
Romaniuk, A.; Ryffa, T.; Rowiński, W.; Olszewski, W.L. 1989: Prolongation of heart allograft survival in course of donor specific antigen and alloserum treatment in the rat Archivum Immunologiae et Therapiae Experimentalis 37(3-4): 253-260
Schulak, J.A.; Cooke, J.C.; Herrmann, M.J. 1990: Failure of donor irradiation and graft lymph node reduction to prolong pancreas allograft survival in cyclosporine- and donor-specific transfusion-treated hosts Transplantation 50(2): 341-343
Goss, J.A.; Nakafusa, Y.; Yu, S.; Flye, M.W. 1993: Reduction in donor-specific cytotoxic T lymphocytes and prolonged cardiac allograft survival following intrathymic donor splenocyte injection Transplantation Proceedings 25(1 Part 1): 286-288
Hale, D.A.; Gottschalk, R.; Fukuzaki, T.; Wood, M.L.; Maki, T.; Monaco, A.P. 1997: Superiority of sirolimus (rapamycin) over cyclosporine in augmenting allograft and xenograft survival in mice treated with antilymphocyte serum and donor-specific bone marrow Transplantation 63(3): 359-364
Nakaji, K.; Nakata, T.; Yasumura, T.; Ohmori, Y.; Oka, T.; Takada, K.; Muranishi, S. 1988: Prolongation of rat renal allograft survival by injection of a small dose of cyclosporine into the thoracic duct Transplantation Proceedings 20(2 Suppl 2: 298-300
Jaskłowska-Englisz, M.; Olszewski, W.L. 1994: Donor-specific transfusions prolong heart allograft survival but lymphocytes from the same donor are acutely rejected Transplantation Proceedings 26(6): 3463
Kagawa, K.; Kasahara, K.; Sakurai, Y.; Omoto, K.; Masuda, A.; Nonoyama, A.; Kagawa, T. 1987: Prolongation of rat cardiac allograft survival with arachidonic acid metabolism inhibitor Transplantation Proceedings 19(1 Part 2): 1308-1311
Matsumoto, T.; Sakagami, K.; Orita, K. 1987: Role of donor specific blood transfusions in prolongation of kidney graft survival Transplantation Proceedings 19(1 Part 3): 2264-2267
Smith, R.M.; Chen, Z.K.; Foulkes, R.; Metcalfe, S.M.; Wraith, D.C. 1997: Prolongation of murine vascularized heart allograft survival by recipient-specific anti-major histocompatibility complex class II antibody Transplantation 64(3): 525-528
Gorczynski, R.M.; Wojcik, D. 1994: A role for nonspecific (cyclosporin A) or specific (monoclonal antibodies to ICAM-1, LFA-1, and IL-10) immunomodulation in the prolongation of skin allografts after antigen-specific pretransplant immunization or transfusion Journal of Immunology 152(4): 2011-2019
Fu, F.; Li, Y.; Qian, S.; Lu, L.; Chambers, F.; Starzl, T.E.; Fung, J.J.; Thomson, A.W. 1996: Costimulatory molecule-deficient dendritic cell progenitors (MHC class II+, CD80dim, CD86-) prolong cardiac allograft survival in nonimmunosuppressed recipients Transplantation 62(5): 659-665
Kamei, T.; Callery, M.P.; Flye, M.W. 1989: Intravenous and portal venous administration of modified donor antigen prolongs rat parathyroid allograft survival Surgery 106(6): 1028-1034; Discussion: 1034-1035
MacLeod, A.M.; Mason, R.J.; Power, D.A.; Edward, N.; Stewart, K.N.; Shewan, G.; Catto, G.R. 1983: Pretransplant antibodies and renal allograft survival Proceedings of the European Dialysis and Transplant Association. European Dialysis and Transplant Association 20: 305-308
Ketchum, R.J.; Moore, W.V.; Hegre, O.D. 1992: Increased islet allograft survival after extended culture by a mechanism other than depletion of donor APCs. Lack of correlation between the elimination of donor MHC class II-positive accessory cells and increased transplantability Transplantation 54(2): 347-351
Oluwole, S.F.; Fawwaz, R.A.; Reemtsma, K.; Hardy, M.A. 1988: The role of suppressor T lymphocytes in the induction of specific immunologic unresponsiveness to rat cardiac allografts by donor leukocytes and cyclosporine Transplantation Proceedings 20(3 Suppl 3: 1038-1044